Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Mental Health in Musculoskeletal Trauma
NCT04850222Phase 2Completed
- Sponsor
- University of Florida
- Start
- Sep 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in major depressive disorder (MDD), anxiety disorder, post-traumatic stress disorder (PTSD), sponsored by University of Florida. Started Sep 2021; status: completed.
02
Drugs
fluoxetine
03
Conditions
major depressive disorder (MDD)anxiety disorderpost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04850222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850222.